CD8A and type 1 diabetes mellitus: Using this strategy, we were able to demonstrate the presence of islet-antigen-specific CD4+ and CD8+ T cells in Type 1 diabetes (T1D) patients under immunosuppressive treatments after allogeneic islet transplantation [13].